Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

323.50p
   
  • Change Today:
      6.00p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 146,053
  • Market Cap: £323.50m
  • RiskGrade: 125

Income Statement - Normalised

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-10 31-Dec-09
Continuing Operations          
Revenue 87.73 64.06 66.78 11.15 19.12
           
EBITDA (5.69) (14.47) 13.38 (7.02) (4.91)
Depreciation & Amortisation n/a n/a (4.36) (1.04) (0.31)
           
Operating Profit/(Loss) (5.69) (14.47) 9.02 (8.06) (5.22)
Interest Payable (0.91) (6.53) (8.97) (0.01) (0.03)
Interest Receivable/Investment Income 0.03 0.10 0.07 0.22 0.67
           
Group Profit after Interest (6.57) (20.89) 0.12 (7.86) (4.58)
Share of Assoc Cos/JV Profits n/a n/a n/a n/a n/a
           
Profit Before Tax (6.57) (20.89) 0.12 (7.86) (4.58)
Tax 0.33 4.82 2.53 1.51 1.58
           
Profit After Tax (6.25) (16.07) 2.65 (6.34) (3.00)
           
Discontinued Operations          
Profit After Tax n/a n/a n/a n/a n/a
           
PROFIT FOR PERIOD (6.24) (16.07) 2.65 (6.34) (3.00)
           
Attributable to:          
Equity Holders of Parent Company (6.24) (16.07) 2.65 (6.34) (3.00)
Minority Interests n/a n/a n/a n/a n/a
           
Equity Dividends cn/a cn/a cn/a cn/a cn/a
Retained Profit/(Loss) for the Financial Year c(6.24) c(16.07) c2.65 c(6.34) c(3.00)


Per Share Record - Normalised 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-10 31-Dec-09
Continuing EPS          
Earnings per Share - Basic (7.81p) (22.10p) 4.06p (1.17p) (0.56p)
Earnings per Share - Diluted (7.81p) (22.10p) 4.06p (1.17p) (0.56p)
Earnings per Share - Adjusted (7.81p) (22.10p) 11.57p (58.50p) (88.00p)
Continuing and Discontinued EPS          
Earnings per Share - Basic (7.81p) (22.10p) 0.51p (1.17p) (0.56p)
Earnings per Share - Diluted (7.81p) (22.10p) 0.51p (1.17p) (0.56p)
Earnings per Share - Adjusted (7.81p) (22.10p) 11.57p (58.50p) (88.00p)
           
Dividend per Share n/a n/a n/a n/a n/a


Key Financals 31-Dec-20 31-Dec-19 31-Dec-18 31-Dec-10 31-Dec-09
Shares in Issue (millions)          
Shares in Issue - Year End 83.32 n/a 66.10 544.88 541.19
Weighted Average 79.94 72.71 65.19 543.92 539.87
Diluted 79.94 72.71 65.19 543.92 539.87
           
Performance Ratios          
Continuing Operations          
Operating Margin (6.49%) (22.58%) 13.51% (72.29%) (27.28%)
Return on Capital Employed n/a n/a 1.46% n/a n/a
Continuing Operations & Discontinued Operations          
Return on Equity (5.27%) (19.82%) 0.91% (52.39%) (13.95%)
           
Financial Status          
Continuing Operations          
Interest Cover - Continuing (6.21) (2.20) 1.01 (522.67) (137.79)
Revenue per Share 109.74p 88.10p 12.80p 2.05p 3.54p
Pre-Tax Profit Per Share - Continuing (8.22p) (28.73p) 0.023p (1.44p) (0.85p)
           
Market Data          
Continuing Operations          
Earnings Per Share Growth - Basic n/a n/a n/a n/a n/a
Earnings Per Share Growth - Diluted n/a n/a n/a n/a n/a
PE Ratio - Company Adjusted n/a n/a 174.1 n/a n/a
PEG - Company Adjusted n/a n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
Continuing Operations & Discontinued Operations          
Earnings per Share - Company Adjusted n/a n/a n/a n/a n/a
Earnings per Share - Diluted n/a n/a n/a n/a n/a
PE Ratio - Company Adjusted n/a n/a 1,393.2 n/a n/a
PEG - Company Adjusted n/a n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
           
Market Capitalisation £ (Millions) 858.20 n/a 467.48 1,506.58 2,886.03
Dividend per Share n/a n/a n/a n/a n/a
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a

Key

* GAAP

a. Includes discontinued activities

b. Includes preference dividends

c. Not disclosed under IFRS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page